Effect uracil herpes simplex virus type infection immunosuppressed mice uracil BV-araU mortality rates cyclophosphamide-treated immunosuppressed mice CYP mice virulent strain herpes simplex virus type ii CYP mice virulent strain doses mg/kg body weight mg/kg degree efficacy BV-araU equivalent acyclovir CYP mice virulent strain BV-araU mg/kg viral growth various organs CYP mice 